“With mRNA approaches, you don’t have to grow ... it provides a very good starting point in terms of understanding the structure of viral proteins, especially on the surface of viruses ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

"GSK has an industry-leading pipeline of vaccines and Phil's scientific expertise and significant experience with key innovative technologies, such as mRNA, structure-based antigen design and ...

During an awards ceremony at Rensselaer Polytechnic Institute (RPI) today, Chemical and Biological Engineering professors ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...

Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...

Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key regulatory hurdle at its flagship production plant in the United Kingdom.